{
  "nct_id": "NCT21168821",
  "indication": "Non-Small Cell Lung Cancer",
  "phase": "Phase 3",
  "sample_size": 887,
  "duration_weeks": 45,
  "dropout_rate": 0.2,
  "blinding": "open-label",
  "control_arm": "standard of care",
  "primary_endpoints": [
    "Overall survival"
  ],
  "secondary_endpoints": [
    "Progression-free survival"
  ],
  "outcome_summary": "Statistically significant improvement on primary and key secondary endpoints",
  "success": 1,
  "start_date": "2024-01-29",
  "completion_date": "2024-12-09"
}